Spindle Biotech

Toronto, Canada Founded: 2016 • Age: 10 yrs Acquired By Applied DNA Sciences
Gene editing research tools are provided using synthetic RNA.

About Spindle Biotech

Spindle Biotech is a Healthcare company based in Toronto (Canada) founded in 2016, and was acquired by Applied DNA Sciences in July 2023. Gene editing research tools are provided using synthetic RNA. Spindle Biotech has raised $250 thousand across 1 funding round from investors including Applied DNA Sciences and SOSV. The company has 4 employees. Its chief executive, as recorded, is Aaron Chung. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.

Company details

Spindle Biotech was founded in 2016 in Toronto, Canada, within the biotechnology sector. Tools for gene editing research are supplied, with synthetic RNA employed instead of plasmid DNA to reduce off-target effects through natural degradation after a defined period. CRISPR applications are supported via high-throughput approaches, including phenotypic screening that identifies required targets for research operations.

Key Metrics

Funding Insights of Spindle Biotech

Spindle Biotech has successfully raised a total of $250K through 1 strategic funding round. The most recent funding activity was a Seed round of $250 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $250,000
  • Total Rounds 1
  • Last Round Seed β€” $250,000
  • First Round $250,000

    (Jun 2019)

  • Investors Count 1

All 1 funding rounds of Spindle Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2019$250,000Seed–SOSV
–
Valuation history

2 investors in total: 2 institutional.

Investors in Spindle Biotech

Spindle Biotech has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Applied DNA Sciences and SOSV.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital and accelerator services are provided across multiple sectors.
sosv.comCork, Ireland
Botanical-DNA-based security and authentication solutions are developed.
1983adnas.comStony Brook, United States
Premium access

Investor details for Spindle Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Spindle Biotech

2 people are tracked at Spindle Biotech (2 in leadership); the tracked headcount is 4.

NameRoleGroup
Aaron Chung
CEOLeadership
Nat Brinn
Co-FounderLeadership
Premium access

Complete people profiles for Spindle Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Spindle Biotech

3 dated milestones of Spindle Biotech across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Spindle Biotech is founded.
  2. Funding First funding round of $250K.
  3. Exit Acquired by Applied DNA Sciences.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Spindle Biotech

Premium access

Complete news archive for Spindle Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Spindle Biotech

Spindle Biotech was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Spindle Biotech is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Aaron Chung is the CEO of Spindle Biotech, as recorded in our data.

Spindle Biotech is a funded company, having raised a total of $250K across 1 funding round to date. The company's 1st funding round was a Seed of $250K, raised on Jun 2019.

Spindle Biotech has 4 employees.

Spindle Biotech was founded in 2016 in Toronto, Canada, within the biotechnology sector. Tools for gene editing research are supplied, with synthetic RNA employed instead of plasmid DNA to reduce off-target effects through natural degradation after a defined period. CRISPR applications are supported via high-throughput approaches, including phenotypic screening that identifies required targets for research operations.

Spindle Biotech has 2 investors. Key investors include Applied DNA Sciences, and SOSV.

Yes. Spindle Biotech was acquired by Applied DNA Sciences in July 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available